AGP Picks
View all

California Health Watch
Provided by AGP

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on April 23, 2026

Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications
Apr. 23, 2026

Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications

Indeterminate GlobeNewswire
Theialife Appoints Thomas Ruggia as President and Chief Executive Officer to Advance Phase-3 Ready Oral Myopia Therapy and Scale Ophthalmology Platform
Apr. 23, 2026

Theialife Appoints Thomas Ruggia as President and Chief Executive Officer to Advance Phase-3 Ready Oral Myopia Therapy and Scale Ophthalmology Platform

Indeterminate GlobeNewswire
Belite Bio to Participate in Four Upcoming Investor Conferences
Apr. 23, 2026

Belite Bio to Participate in Four Upcoming Investor Conferences

Indeterminate GlobeNewswire
CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)
Apr. 23, 2026

CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)

Indeterminate GlobeNewswire
GB HealthWatch Launches AI-Ready Genetic Reports for the GB Longevity100 Suite
Apr. 23, 2026

GB HealthWatch Launches AI-Ready Genetic Reports for the GB Longevity100 Suite

Indeterminate GlobeNewswire
Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit
Apr. 23, 2026

Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit

Indeterminate GlobeNewswire
Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™
Apr. 23, 2026

Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™

Indeterminate GlobeNewswire
Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors
Apr. 23, 2026

Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors

Indeterminate GlobeNewswire
Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan
Apr. 23, 2026

Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan

Indeterminate GlobeNewswire
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2025 Financial Results
Apr. 23, 2026

Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2025 Financial Results

Indeterminate GlobeNewswire
The Joint Corp. to Report 2026 First Quarter Results on Thursday, May 7 and Host Conference Call and Webcast
Apr. 23, 2026

The Joint Corp. to Report 2026 First Quarter Results on Thursday, May 7 and Host Conference Call and Webcast

Indeterminate GlobeNewswire
Ocugen to Present at April 2026 Investor and Industry Conferences
Apr. 23, 2026

Ocugen to Present at April 2026 Investor and Industry Conferences

Indeterminate GlobeNewswire
Radiopharm Theranostics Reports Business Update
Apr. 23, 2026

Radiopharm Theranostics Reports Business Update

Indeterminate GlobeNewswire
Genenta signs Definitive Agreements with Sophia High Tech
Apr. 23, 2026

Genenta signs Definitive Agreements with Sophia High Tech

Indeterminate GlobeNewswire
Antag Therapeutics to present data on AT7687, its first-in-class GIPR antagonist peptide at the American Diabetes Association’s 2026 Scientific Sessions
Apr. 23, 2026

Antag Therapeutics to present data on AT7687, its first-in-class GIPR antagonist peptide at the American Diabetes Association’s 2026 Scientific Sessions

Indeterminate GlobeNewswire
Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026
Apr. 23, 2026

Kymera Therapeutics to Report First Quarter 2026 Financial Results on April 30, 2026

Indeterminate GlobeNewswire
Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026
Apr. 23, 2026

Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026

Indeterminate GlobeNewswire
AAFA Highlights New Resources for Nasal Polyps in Recognition of Global CRSwNP Awareness Day
Apr. 23, 2026

AAFA Highlights New Resources for Nasal Polyps in Recognition of Global CRSwNP Awareness Day

Indeterminate GlobeNewswire
Conavi Medical Awarded 2026 TAG Innovation Award
Apr. 23, 2026

Conavi Medical Awarded 2026 TAG Innovation Award

Indeterminate GlobeNewswire
Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Apr. 23, 2026

Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.